Peter Pramstaller

Peter Pramstaller

Peter Pramstaller

Head of Institute
Institute for Biomedicine

T 105 550 1740 93+


Peter P. Pramstaller is the founding director and head of the Institute for Biomedicine. As clinical neurologist, biomedical researcher and manager, he had the opportunity and privilege over the last 20 years to oversee and coordinate large, multilevel cross-disciplinary research projects, and to network with the international clinical-scientific community and industry.

Peter studied Medicine at the University of Innsbruck and pursued his postgraduate training and specialization in Neurology at the University of Verona, Heidelberg and the National Hospital of Neurology and Neurosurgery, Queen Square, London. In 2003 he joined the medical faculty at the University of Luebeck (Germany), where he is currently Associate Professor.

Peter's primary research focus is the molecular genetics of movement disorders, with a special focus on common age-related neurodegenerative disorders such as Parkinson's disease (PD). After his return from the National Hospital of Neurology and Neurosurgery, Queen Square (1993-1995) he started a large scale neuroepidemiology project on PD and related disorders (NEPT-Study) in South Tyrol (Northern Italy), applying a combination of epidemiology and pedigree-based genetics. Strengthened by the success of these familial studies, in 2002 he started the “GenNova Health Care Program,” an extensive, two-stage survey aimed at characterizing the genetic epidemiology of Mendelian and complex diseases in South Tyrolean population isolates (MICROS-Study). In 2004 GenNova became the Institute of Genetic Medicine, focusing its studies on genetic-epidemiological analyses among the South Tyrolean population isolates. In 2009 the institute grew into today’s Institute for Biomedicine, which in 2011 launched the CHRIS-Study (Cooperative Health Research In South Tyrol), a large prospective population cohort study, focused on understanding how the interaction between factors such as genomic, metabolomic and environmental variation contributes to human health and disease.

Peter strongly believes in transdisciplinarity, convergence and synergy. Thus, beside his biomedical research and clinical-translational focus, he has a strong interest in the development and application of novel leadership and management models in science and healthcare.

LinkedIn profile ​​​​​​​

Google Scholar profile

PubMed profile


Rettet die Medizin: Wie Ärzte das Ruder wieder selbst in die Hand nehmen können. Mit einem Geleitwort von Fredmund Malik

Rescue the Doctor: What Doctors Urgently Need to Know About the New World of Health Care

Doctors need lessons in management


1 - 2


Partnership to Accelerate Covid-19 rEsearch in South Tyrol

Duration: - Funding:
Provincial P.-L.P. 14. Research projects (Province BZ funding /Project)

MAGAZINE Science Stories that Inspire

Free of symptoms but not of fears

Free of symptoms but not of fears

Incomplete penetrance in genetic diseases and arrhythmogenic cardiomyopathy


Molecule identified that could counteract arrhythmogenic cardiomyopathy